Cart
sales@molnova.com
Home - Products - Immunology/Inflammation - NOS - AVE-9488

AVE-9488

CAS No. 291756-32-6

AVE-9488( —— )

Catalog No. M34513 CAS No. 291756-32-6

AVE-9488 is a novel endothelial NO synthase (eNOS) enhancer that upregulates eNOS expression, induces NO production, and may ameliorate portal hypertension.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 411 In Stock
10MG 562 In Stock
25MG 866 In Stock
50MG 1097 In Stock
100MG 1395 In Stock
200MG 1841 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    AVE-9488
  • Note
    Research use only, not for human use.
  • Brief Description
    AVE-9488 is a novel endothelial NO synthase (eNOS) enhancer that upregulates eNOS expression, induces NO production, and may ameliorate portal hypertension.
  • Description
    AVE-9488 is a novel endothelial NO synthase (eNOS) enhancer that upregulates eNOS expression, induces NO production, and may ameliorate portal hypertension.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    NOS | NO Synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    291756-32-6
  • Formula Weight
    255.29
  • Molecular Formula
    C16H14FNO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1CC=2C=CC=CC2C1)C3=CC=C(F)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • EX-A5758

    EX-A5758 is a novel putative small molecule nNOS-NOS1AP inhibitor, suppressing inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.

  • SDMA

    SDMA (Symmetric dimethylarginine) is an arginine derivative and an endogenous inhibitor of nitric oxide (NO) synthase activity.

  • L-NIL

    L-NIL is a selective nitric oxide synthase (iNOS) inhibitor that reverses burn-induced activation of glycogen synthase kinase-3β in rat skeletal muscle and may slow the progression of squamous cell carcinoma lung.

Sign In Join Free